A high-volume automated monkeypox diagnostic from Roche Diagnostics Corp. has been granted an Emergency Use Authorization by the US Food and Drugs Administration, the company announced recently. The cobas MPXV is the first test for the disease to be authorized based on clinical trials that used actual patient samples.
The cobas MPXV, which can be used with Roche’s cobas 6800/8000 systems, is a real-time polymerase chain reaction (PCR) test that uses lesion-swab samples. It targets two different regions of...